Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership cut its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 77.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 695,922 shares of the company's stock after selling 2,382,566 shares during the quarter. Arrowstreet Capital Limited Partnership owned about 0.29% of Cardinal Health worth $82,307,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. lifted its position in Cardinal Health by 35.2% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company's stock valued at $3,871,000 after acquiring an additional 8,471 shares in the last quarter. CHURCHILL MANAGEMENT Corp lifted its position in shares of Cardinal Health by 1.5% during the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company's stock valued at $28,435,000 after buying an additional 3,576 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Cardinal Health by 0.7% in the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company's stock worth $633,298,000 after purchasing an additional 42,082 shares during the period. Consolidated Planning Corp increased its stake in Cardinal Health by 40.0% in the 4th quarter. Consolidated Planning Corp now owns 8,926 shares of the company's stock worth $1,056,000 after buying an additional 2,552 shares in the last quarter. Finally, Flputnam Investment Management Co. raised its stake in Cardinal Health by 1.8% during the 4th quarter. Flputnam Investment Management Co. now owns 180,586 shares of the company's stock valued at $21,358,000 after purchasing an additional 3,148 shares during the period. 87.17% of the stock is owned by institutional investors.

Cardinal Health Price Performance

Shares of CAH stock traded down $7.72 during trading hours on Friday, hitting $129.37. The stock had a trading volume of 3,779,368 shares, compared to its average volume of 2,132,250. The stock's 50 day moving average is $129.15 and its 200 day moving average is $121.62. The firm has a market capitalization of $31.25 billion, a PE ratio of 24.14, a PEG ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $139.50.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, equities analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.56%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is 37.69%.

Analyst Ratings Changes

A number of equities research analysts recently commented on CAH shares. Citigroup boosted their target price on Cardinal Health from $120.00 to $129.00 and gave the stock a "neutral" rating in a research report on Friday, January 10th. TD Cowen raised shares of Cardinal Health from a "hold" rating to a "buy" rating and lifted their price target for the stock from $130.00 to $144.00 in a research note on Wednesday, January 8th. Morgan Stanley increased their target price on Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a research note on Friday, January 31st. Jefferies Financial Group raised shares of Cardinal Health from a "hold" rating to a "buy" rating and raised their target price for the stock from $140.00 to $150.00 in a research report on Wednesday, February 5th. Finally, Wells Fargo & Company lifted their price objective on Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a report on Tuesday, February 4th. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, Cardinal Health has an average rating of "Moderate Buy" and a consensus price target of $140.14.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.